Welcome to the Journal
Clinical Investigation (OACLI) (2041-6792) plays significant role in the diagnosis, therapy and cure of diseases apart from new drug development and delivery. The Clinical Investigation Journal offers an Open Access platform to the scholars, amateurs, clinical practitioners and students that are keen in contributing their findings in this field.
Clinical Investigation (OACLI) caters to the clinical drug development and methodology, facilitating rapid publication of research outcome on new drug data from human studies. The journal includes topics like safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. Also the journal publishes expert analysis of ongoing Phase I–IV trials and perspectives on how to run future trials.
The journal offers thoroughly reviewed original research as research articles, review articles, Clinical Trial Protocols, Clinical Trial Perspectives, Clinical Trial Outcomes, Clinical Trial Reports, Clinical Trial Methodologies, Clinical Trial phase I-IV findings, Commentaries on Clinical trials, case studies, commentaries, Short Communication, and Letters to the Editors in the areas not limited to Regulations and guidelines on drug development and delivery, legal and ethical issues of clinical trials, issues of testing of novel drugs, new medical procedure, new medical devices etc.
Submit your manuscripts online at Editorial Tracking online submission: https://www.scholarscentral.org/submissions/clinical-investigation.html
Contact Editorial Office or send attachment of manuscript at any of the following mail id: [email protected]
Recently Published Articles
Mini Review p. 185-189
Rationale for a randomized, placebo-controlled, Phase 2 study of Rejuveinix (RJX) in COVID-19 patients with acute lung injury and hypoxemic respiratory failure
Author(s): Kristina Cabala, Jackie Earabino, Peter Pacult, Fatih M. Uckun*
New drug products that can effectively improve the ability of supportive care to reduce the risk of ARDS or its mortality rate in COVID-19 patients are urgently needed. Rejuveinix (RJX) is a..
Comparative Evaluation of MTA Pulpotomy and Laser-Assisted MTA Pulpotomy in Primary Teeth: A Randomized Clinical Trial
Author(s): Kranthi R Kumar, Maneesha Das, Gautam Singh, Malu L Madhu, Jeswin M Thomas, Arumugam Esai Amutha Prabha
Context and Aim: Formocresol has been used as the material of choice (gold standard) for pulpotomy procedures because of the ease of use but was discouraged due to its potential immune sensi..
Author(s): Azhar Hussain, Madeeha Malik, Sadia Shabnum, Ayisha Hashmi
Introduction: Obesity has become a serious global epidemic which poses a major health hazard to the human being. Globally, changing trends such as high intake of fast food, sedentary lifesty..
Author(s): Tharun C Varghese, Anna Susan Paul, Santhosh Soans
Aim: Pain management in newborn infants especially for mild to moderate pain is underused. The use of sucrose and glucose are found to be effective. This study is to find the effect of oral ..